Mechanism of pyrimethamine-induced megaloblastosis in human bone marrow.
D000748:Anemia, Macrocytic / Q000139:chemically induced; D001853:Bone Marrow / Q000187:drug effects / Q000378:metabolism; D001855:Bone Marrow Diseases / Q000139:chemically induced*; D002825:Chorioretinitis / Q000188:drug therapy; D046508:Culture Techniques; D004247:DNA / Q000096:biosynthesis; D003857:Deoxyuridine / Q000378:metabolism; D004912:Erythrocytes; D005260:Female; D005472:Fluorouracil / Q000494:pharmacology; D005492:Folic Acid / Q000378:metabolism / Q000627:therapeutic use; D005493:Folic Acid Antagonists / Q000494:pharmacology; D006801:Humans; D008727:Methotrexate / Q000494:pharmacology; D008875:Middle Aged; D009711:Nucleotides / Q000096:biosynthesis; D010084:Oxidation-Reduction; D011739:Pyrimethamine / Q000009:adverse effects* / Q000494:pharmacology; D013936:Thymidine / Q000096:biosynthesis / Q000378:metabolism; D014316:Tritium
D005493:Folic Acid Antagonists; D009711:Nucleotides; D014316:Tritium; D004247:DNA; D005492:Folic Acid; D005472:Fluorouracil; D013936:Thymidine; D003857:Deoxyuridine; D008727:Methotrexate; D011739:Pyrimethamine